feed,title,long_url,short_url
Investors,FedEx Expected To Report Slight Revenue Decline With 2024 Guidance At Risk,https://www.investors.com/news/fedex-stock-revenue-decline-expected-with-2024-guidance-at-risk/,https://da.gd/O0ZRq
Investors,"Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results",https://www.investors.com/news/technology/biotech-stocks-argenx-immunvant-tourmaline-generalized-myasthenia-gravis/,https://da.gd/94sOM8
